A total of 176 patients with gastrointestinal lymphomas were reviewed. According to a modified staging classification, 51 of them had stage I/II disease and the remaining 125 had stage III/IV disease. In most cases (68%), the histology was intermediate-grade according to the NIH working formulation, and the B-cell immunophenotype was involved in 89% of the 45 cases with a known immunophenotype. The primary site was the stomach in 56% of cases and the bowel in 44%. A significantly higher proportion (P=0.001) of those with bowel lymphomas had stage III/IV disease (88% vs 57%). The primary gastrointestinal lesion was resected in 122 patients, including all 51 cases of stage I/II disease. In all, 8 stage I/II patients were given radiotherapy alone following surgery and the other 43 underwent chemotherapy; of the latter, 19 received additional radiotherapy following chemotherapy. Chemotherapy was also given to 112 stage III/IV patients, 42 of whom underwent additional radiotherapy. Factors associated with a poorer prognosis included advanced disease, bowel lymphoma and advanced age. Although the complete response (CR) rate according to disease stage was similar, stage I/II patients receiving chemotherapy showed a significantly lower relapse rate, better disease-free survival following CR and improved survival as compared with those receiving radiotherapy alone. However, additional radiotherapy following chemotherapy did not further improve the clinical outcome.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Anderson T, Bender RA, Fisher RI, De Vita VT, Chabner BA, Berard CW, Norton L, Young RC (1977) Combination chemotherapy in non-Hodgkin's lymphomas; results of long-term follow up. Cancer Treat Rep 61: 1057
Aozasa K, Ueda T, Kurata A, Kim CW, Inoue M, Matsuura N, Takenchi T, Tsujimura T, Kadin ME (1988) Prognostic value of histological and clinical factors in 56 patients with gastrointestinal lymphoma. Cancer 61: 309
Brooks JJ, Enterline HT (1983) Primary gastric lymphomas — a clinical pathologic study of 58 cases with long term follow-up and literature review. Cancer 51: 710
Crowther D, Rankin EM (1982) Staging patients with non-Hodgkin's lymphomas. Br J Haematol 52: 357
De Vita VT, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73: 881
Fleming ID, Mitchell S, Dilawari RA (1982) The role of surgery in the managment of gastric lymphoma. Cancer 49: 1135
Haber DA, Mayer RJ (1988) Primary gastrointestinal lymphoma. Semin Oncol 15: 154
Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L (1980) Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 46: 215
Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK (1984) Clinicopathological features of malignant lymphomas in 294 Hong Kong Chinese patients — retrospective study covering an eight-year period. Int J Cancer 34: 143
Ho FCS, Loke SL, Hui PK, Todd D (1986) Immunohistological subtypes of non-Hodgkin's lymphomas in Hong Kong chinese. Pathology 18: 426
Hoogstraten B (1984) Reporting treatment results in solid tumours. In: Byse ME, Staquet MJ, Sylvester RJ (eds) Cancer clinical trials, methods and practice. Oxford University Press, Oxford, p 139
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457
Lewin KJ, Ranchod M, Dorfman RF (1978) Lymphomas of the gastrointestinal tract, a study of 117 cases presenting with gastrointestinal disease. Cancer 42: 693
Liang R, Todd D, Chan TK, Ng RP, Ho FCS (1987) Gastrointestinal lymphoma in Chinese — a retrospective analysis. Hematol Oncol 5: 115
List AF, Greer JP, Cansar JC, Stein RS, Johnson DH, Reynolds VH, Greco FA, Flexner JM, Hande KR (1988) Non-Hodgkin's lymphoma of the gastrointestinal tract, an analysis of clinical and pathologic features affecting outcome. J Clin Oncol 6: 1125
McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gable JF, Jones SE, Grozea PN, Guttermon J, Coltman C, Moon TE (1976) Hydroxyldaunorubicin (Adriamycin) combination chemotherapy in malignant lymphomas. Cancer 38: 1484
Non-Hodgkin's Lymphoma Pathologic Classification Projects (1982) NCI-sponsored study of classifications of non-Hodgkins lymphomas. Cancer 49: 2112
Rosenfelt F, Rosenbery SA (1980) Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions: the Stanford experience. Cancer 45: 2188
Schein PS, De Vita VT Jr, Hubbard S, Chabner BA, Canellos GP, Berard C, Young RC (1976) Bleomycin, Adriamycin, cyclophosphamide, vincristine and prednisone (BACOP) combination chemotherapy in the treatment of advanced aggressive histiocytic lymphomas. Ann Intern Med 85: 417
Shepherd FA, Evans KW, Kutas G, Yan JC, Dang P, Scott JG, Farquharson HA, Francombe WH, Bailey D, Baker MA (1988): Chemotherapy following surgery for stage IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract. J Clin Oncol 6: 253
Steward WP, Harris M, Wagstaff J, Scarffe JH, Deakin DP, Todd IDH, Crowther D (1985) A retrospective study of the treatment of high grade histology non-Hodgkin's lymphoma involving the gastro-intestinal tract. Eur J Cancer Clin Oncol 21: 1195
Shipp MA, Harrington DP, Klatt MM, Jochelson MS, Pinkus GS, Marshall JL, Rosenthal DS, Skarin AT, Canellos GP (1986) Identification of major prognostic subgroups of patients with diffuse largecell lymphomas treated with m-BACOD or M-BACOD. Ann Intern Med 104: 757
Shiu MH, Nisce LZ, Pinna A, Straus DJ, Torne M, Filippi DA, Lee BJ (1986) Recent results of multimodality therapy for gastric lymphoma. Cancer 58: 1389
Weingrad DN, Decosse JJ, Sherlock P, Straus D, Lieberman PH, Filippa DA (1982) Primary gastrointestinal lymphoma, a 30-year review. Cancer 49: 1258
Supported by a grant from the Haematology Research Fund, Department of Medicine, University of Hong Kong
About this article
Cite this article
Liang, R., Chiu, E., Todd, D. et al. Chemotherapy for early-stage gastrointestinal lymphoma. Cancer Chemother. Pharmacol. 27, 385–388 (1991). https://doi.org/10.1007/BF00688862
- Clinical Outcome
- Cancer Research
- Poor Prognosis
- Advanced Disease